Vestcor Inc Grows Holdings in Astera Labs, Inc. $ALAB

Vestcor Inc raised its position in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 244.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,784 shares of the company’s stock after buying an additional 2,684 shares during the period. Vestcor Inc’s holdings in Astera Labs were worth $630,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Assetmark Inc. increased its holdings in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank increased its holdings in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC purchased a new position in Astera Labs in the fourth quarter valued at $33,000. Wexford Capital LP purchased a new position in Astera Labs in the third quarter valued at $39,000. Finally, National Bank of Canada FI increased its holdings in Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after buying an additional 124 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Up 9.2%

Shares of NASDAQ ALAB opened at $346.33 on Tuesday. The company’s 50-day simple moving average is $217.60 and its 200-day simple moving average is $173.27. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $372.37. The firm has a market cap of $59.36 billion, a price-to-earnings ratio of 234.01, a price-to-earnings-growth ratio of 4.20 and a beta of 3.94.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the business earned $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the transaction, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This trade represents a 0.75% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares in the company, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 2,321,256 shares of company stock worth $480,893,146 in the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Barclays lifted their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price on the stock. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Finally, TD Cowen lifted their target price on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Read Our Latest Stock Report on ALAB

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.